Astellas Pharma (Astellas Pharma) Days Payable : 176.63 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma Days Payable?

Astellas Pharma's average Accounts Payable for the three months ended in Dec. 2023 was $1,020 Mil. Astellas Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was $527 Mil. Hence, Astellas Pharma's Days Payable for the three months ended in Dec. 2023 was 176.63.

The historical rank and industry rank for Astellas Pharma's Days Payable or its related term are showing as below:

ALPMY' s Days Payable Range Over the Past 10 Years
Min: 171.5 Med: 211.05 Max: 235.58
Current: 184.25

During the past 13 years, Astellas Pharma's highest Days Payable was 235.58. The lowest was 171.50. And the median was 211.05.

ALPMY's Days Payable is ranked better than
80.76% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.3 vs ALPMY: 184.25

Astellas Pharma's Days Payable increased from Dec. 2022 (166.88) to Dec. 2023 (176.63). It may suggest that Astellas Pharma delayed paying its suppliers.

Astellas Pharma Days Payable Historical Data

The historical data trend for Astellas Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Days Payable Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Payable

Get a 7-Day Free Trial

208.07

231.76

221.30

192.49

182.03

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															166.88	200.16	189.75	179.07	176.63

Competitive Comparison of Astellas Pharma's Days Payable

For the Drug Manufacturers - General subindustry, Astellas Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Days Payable falls into.

Astellas Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Astellas Pharma's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (1102.563	+	1049.166)	/	2 )	/	2157.293	*	365
=	1075.8645					/	2157.293	*	365
=	182.03

Astellas Pharma's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (995.976	+	1044.759)	/	2 )	/	527.13	*	365 / 4
=	1020.3675					/	527.13	*	365 / 4
=	176.63

Astellas Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.